$338.83
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Country

US

CEO

Mr. Adam Schechter

IPO date

1991

Employees

71,000

ISIN

US5049221055

Key stats

Open

$338.73

Volume

792.95K

Market cap

$27.28B

Prev. close

$336.34

Impl / hst vl

-

Open interest

$0.00

$334.40

Day’s Range

$339.04

$245.00

52W Range

$338.19

Valuation

61
Valuation score
Undervalued
P/E
26.10
P/S
1.82
P/B
3.04
Current ratio
1.80
Debt / Equity
0.69
ROE
11.57%
Gross margin
29.80%
Income growth
7.52%
FCF growth
345.25

Sep

11

Dividends

The next payment date will be Sep 11, 2026

Div. per Share

$0.72

Div. Yield

0.21%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 12 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$333.25
The top 20 analysts forecasts that 12-month price may decrease by 1.65%, with a low of $272.70 and a high of $378.00
$272.70
Low
$333.25
Avg
$378.00
High
Current price

Earnings

Q2 ‘26 revenue
$3.73B
Q2 ‘26 net income
$298.70M
Revenue
Net income
Previous EPS
$4.25
Estimate EPS
$4.92
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply